100 YEARS OF VITAMIN D: Historical aspects of vitamin D
暂无分享,去创建一个
[1] J. Pike,et al. Genomic Mechanisms Governing Mineral Homeostasis and the Regulation and Maintenance of Vitamin D Metabolism , 2020, JBMR plus.
[2] R. Bouillon,et al. Vitamin D Binding Protein: A Historic Overview , 2020, Frontiers in Endocrinology.
[3] Glenville Jones,et al. Calcioic acid: In vivo detection and quantification of the terminal C24-oxidation product of 25-hydroxyvitamin D3 and related intermediates in serum of mice treated with 24,25-dihydroxyvitamin D3 , 2019, The Journal of Steroid Biochemistry and Molecular Biology.
[4] Glenville Jones. The discovery and synthesis of the nutritional factor vitamin D. , 2018, International journal of paleopathology.
[5] S. Mays. The epidemiology of rickets in the 17th-19th centuries: Some contributions from documentary sources and their value to palaeopathologists. , 2017, International journal of paleopathology.
[6] O. Mäkitie,et al. Global Consensus Recommendations on Prevention and Management of Nutritional Rickets , 2016, Hormone Research in Paediatrics.
[7] G. Kubica,et al. Isolation and identification , 2015 .
[8] O. Bijvoet,et al. Rickets before the discovery of vitamin D. , 2014, BoneKEy reports.
[9] Glenville Jones,et al. Cytochrome P450-mediated metabolism of vitamin D , 2014, Journal of Lipid Research.
[10] H. DeLuca,et al. CYP2R1 is a major, but not exclusive, contributor to 25-hydroxyvitamin D production in vivo , 2013, Proceedings of the National Academy of Sciences.
[11] E. Schuetz,et al. Interplay between vitamin D and the drug metabolizing enzyme CYP3A4 , 2013, The Journal of Steroid Biochemistry and Molecular Biology.
[12] R. Chesney. Theobald Palm and His Remarkable Observation: How the Sunshine Vitamin Came to Be Recognized , 2012, Nutrients.
[13] M. Konrad,et al. Mutations in CYP24A1 and idiopathic infantile hypercalcemia. , 2011, The New England journal of medicine.
[14] A. Norman,et al. Vitamin D Sterol/VDR Conformational Dynamics and Nongenomic Actions , 2011 .
[15] M. Haussler,et al. Nuclear vitamin D receptor: Natural ligands, molecular structure-function, and transcriptional control of vital genes , 2011 .
[16] H. DeLuca. Historical Overview of Vitamin D , 2011 .
[17] E. Mellanby. An Experimental Investigation on Rickets , 2009 .
[18] L. Swinburne. Rickets and the Fairfax family receipt books. , 2006, Journal of the Royal Society of Medicine.
[19] J. Pettifor. Nutritional rickets: deficiency of vitamin D, calcium, or both? , 2004, The American journal of clinical nutrition.
[20] Jeffrey B. Cheng,et al. Genetic evidence that the human CYP2R1 enzyme is a key vitamin D 25-hydroxylase. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[21] F. Glorieux,et al. Conventional and tissue‐specific inactivation of the 25‐hydroxyvitamin D‐1α‐hydroxylase (CYP27B1) , 2003, Journal of cellular biochemistry.
[22] M. Tremblay,et al. Targeted ablation of the 25-hydroxyvitamin D 1α-hydroxylase enzyme: Evidence for skeletal, reproductive, and immune dysfunction , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[23] K. Inouye,et al. Enzymatic studies on the key enzymes of vitamin D metabolism; 1 alpha-hydroxylase (CYP27B1) and 24-hydroxylase (CYP24). , 2001, Biotechnology annual review.
[24] S. Kato. Vitamin D 1alpha-hydroxylase knockout mice as a hereditary rickets animal model. , 2001, Endocrinology.
[25] F. Glorieux,et al. Deficient mineralization of intramembranous bone in vitamin D-24-hydroxylase-ablated mice is due to elevated 1,25-dihydroxyvitamin D and not to the absence of 24,25-dihydroxyvitamin D. , 2000, Endocrinology.
[26] D. Moras,et al. The crystal structure of the nuclear receptor for vitamin D bound to its natural ligand. , 2000, Molecular cell.
[27] K. Inouye,et al. Metabolic studies using recombinant escherichia coli cells producing rat mitochondrial CYP24 CYP24 can convert 1alpha,25-dihydroxyvitamin D3 to calcitroic acid. , 1999, European journal of biochemistry.
[28] H. DeLuca,et al. Mechanisms and functions of vitamin D. , 2009, Nutrition reviews.
[29] H. DeLuca,et al. Current understanding of the molecular actions of vitamin D. , 1998, Physiological reviews.
[30] M. Demay,et al. Printed in U.S.A. Copyright © 1998 by The Endocrine Society Analysis of Vitamin D-Dependent Calcium-Binding Protein Messenger Ribonucleic Acid Expression in Mice , 2022 .
[31] F. Glorieux,et al. The 25‐Hydroxyvitamin D 1‐Alpha‐Hydroxylase Gene Maps to the Pseudovitamin D‐Deficiency Rickets (PDDR) Disease Locus , 1997, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[32] Tatsuya Yoshizawa,et al. Mice lacking the vitamin D receptor exhibit impaired bone formation, uterine hypoplasia and growth retardation after weaning , 1997, Nature Genetics.
[33] A. Dusso,et al. A new analog of 1,25-(OH)2D3, 19-NOR-1,25-(OH)2D2, suppresses serum PTH and parathyroid gland growth in uremic rats without elevation of intestinal vitamin D receptor content. , 1997, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[34] S. Kato,et al. 25-Hydroxyvitamin D3 1alpha-hydroxylase and vitamin D synthesis. , 1997, Science.
[35] R. Bouillon,et al. Structure-function relationships in the vitamin D endocrine system. , 1995, Endocrine reviews.
[36] K. Ray,et al. Vitamin D binding protein: Genomic structure, functional domains, and mRNA expression in tissues , 1991, The Journal of Steroid Biochemistry and Molecular Biology.
[37] Y. Ohyama,et al. Isolation and characterization of a cytochrome P-450 from rat kidney mitochondria that catalyzes the 24-hydroxylation of 25-hydroxyvitamin D3. , 1991, The Journal of biological chemistry.
[38] J. Shine,et al. Cloning and expression of full-length cDNA encoding human vitamin D receptor. , 1988, Proceedings of the National Academy of Sciences of the United States of America.
[39] M. Haussler,et al. Molecular cloning of complementary DNA encoding the avian receptor for vitamin D. , 1987, Science.
[40] M. Calverley. Synthesis of mc 903, a biologically active vitamin D metabolite analogue , 1987 .
[41] U. Liberman,et al. A cellular defect in hereditary vitamin-D-dependent rickets type II: defective nuclear uptake of 1,25-dihydroxyvitamin D in cultured skin fibroblasts. , 1981, The New England journal of medicine.
[42] H. DeLuca,et al. Isolation and identification of 24-hydroxyvitamin D2 and 24,25-dihydroxyvitamin D2. , 1980, Archives of biochemistry and biophysics.
[43] H. DeLuca,et al. 25-Hydroxyvitamin D3 26,23-lactone: a new in vivo metabolite of vitamin D. , 1979, Biochemistry.
[44] H. DeLuca,et al. Rickets with alopecia: an inborn error of vitamin D metabolism. , 1979, The Journal of pediatrics.
[45] H. Tuppy,et al. Hoppe-Seyler's zeitschrift fur physiologische chemie , 1977 .
[46] H. Harter,et al. Phosphate control and 25-hydroxycholecalciferol administration in preventing experimental renal osteodystrophy in the dog. , 1977, The Journal of clinical investigation.
[47] T. Martin,et al. Metabolism of Vitamin D , 1976, Annals of clinical biochemistry.
[48] D. Chick,et al. Study of rickets in Vienna 1919-1922. , 1976, Medical History.
[49] L. Cavalli-Sforza,et al. Group-specific component (Gc) proteins bind vitamin D and 25-hydroxyvitamin D. , 1975, Proceedings of the National Academy of Sciences of the United States of America.
[50] M. Haussler,et al. Specific binding of 1alpha,25-dihydroxycholecalciferol to nuclear components of chick intestine. , 1975, The Journal of biological chemistry.
[51] H. DeLuca,et al. 25-Hydroxyvitamin D3-24-hydroxylase. Subcellular location and properties. , 1974, Biochemistry.
[52] H. DeLuca,et al. 1,24,25-Trihydroxyvitamin D3. A metabolite of vitamin D3 effective on intestine. , 1973, The Journal of biological chemistry.
[53] Francis Glisson. De Rachitide Sive Marbo Puerili, Qui Vulgo The Rickets Dicitur , 1973 .
[54] H. DeLuca,et al. The regulation of rat liver calciferol-25-hydroxylase. , 1973, The Journal of biological chemistry.
[55] H. DeLuca,et al. 1α-Hydroxy Derivative of Vitamin D3: A Highly Potent Analog of 1α,25-Dihydroxyvitamin D3 , 1973, Science.
[56] H. DeLuca,et al. Pathogenesis of hereditary vitamin-D-dependent rickets. An inborn error of vitamin D metabolism involving defective conversion of 25-hydroxyvitamin D to 1 alpha,25-dihydroxyvitamin D. , 1973, The New England journal of medicine.
[57] H. DeLuca,et al. 25-Hydroxycholecalciferol-1-hydroxylase. Subcellular location and properties. , 1972, The Journal of biological chemistry.
[58] H. DeLuca,et al. Isolation and identification of 24,25-dihydroxycholecalciferol, a metabolite of vitamin D made in the kidney. , 1972, Biochemistry.
[59] H. DeLuca,et al. The synthesis of 1α,25-dihydroxycholecalciferol -- A metabolically active form of vitamin D3 , 1972 .
[60] H. DeLuca,et al. Isolation and identification of 1,25-dihydroxycholecalciferol. A metabolite of vitamin D active in intestine. , 1971, Biochemistry.
[61] H. DeLuca,et al. 25,26-dihydroxycholecalciferol, a metabolite of vitamin D3 with intestinal calcium transport activity. , 1970, Biochemistry.
[62] D. Fraser,et al. Unique Biosynthesis by Kidney of a Biologically Active Vitamin D Metabolite , 1970, Nature.
[63] H. DeLuca,et al. Treatment of renal osteodystrophy with 25-hydroxycholecalciferol. , 1970, Archives of internal medicine.
[64] H. DeLuca,et al. 21,25-dihydroxycholecalciferol. A metabolite of vitamin D3 preferentially active on bone. , 1970, Biochemistry.
[65] M. Haussler,et al. Evidence for the biologically active form of cholecalciferol in the intestine. , 1970, The Journal of biological chemistry.
[66] M. Haussler,et al. Chromosomal receptor for a vitamin D metabolite. , 2009, Proceedings of the National Academy of Sciences of the United States of America.
[67] H. DeLuca,et al. 25-hydroxyergocalciferol: a biologically active metabolite of vitamin D2. , 1969, Biochemical and biophysical research communications.
[68] H. DeLuca,et al. The synthesis of 25-hydroxycholecalciferol. A biologically active metabolite of vitamin D3. , 1969, Biochemistry.
[69] H. DeLuca,et al. 25-hydroxycholecalciferol. A biologically active metabolite of vitamin D3. , 1968, Biochemistry.
[70] M. Haussler,et al. The association of a metabolite of vitamin D3 with intestinal mucosa chromatin in vivo. , 1968, The Journal of biological chemistry.
[71] E. V. Mccollum. The paths to the discovery of vitamins A and D. , 1967, The Journal of nutrition.
[72] H. DeLuca,et al. The synthesis of [1,2-3H]vitamin D3 and the tissue localization of a 0.25-mu-g (10 IU) dose per rat. , 1966, Biochemistry.
[73] R. Mitchell. Idiopathic hypercalcaemia of infants , 1958, Proceedings of the Nutrition Society.
[74] W. Mozołowski. Jędrzej Sniadecki (1768–1838) on the Cure of Rickets , 1939, Nature.
[75] A. Windaus,et al. Über das antirachitisch wirksame Bestrahlungsprodukt ans 7-Dehydro-cholesterin. , 1936 .
[76] H. M. Bruce,et al. The Distillation of Vitamin D. , 1930 .
[77] H. Steenbock,et al. FAT-SOLUBLE VITAMINS XXIII. THE INDUCTION OF GROWTH-PROMOTING AND CALCIFYING PROPERTIES IN FATS AND THEIR UNSAPONIFIABLE CONSTITUENTS BY EXPOSURE TO LIGHT , 1925 .
[78] A. Hess,et al. ANTIRACHITIC PROPERTIES IMPARTED TO INERT FLUIDS AND TO GREEN VEGETABLES BY ULTRA-VIOLET IRRADIATION , 1924 .
[79] H. Steenbock,et al. FAT-SOLUBLE VITAMINS XVII. THE INDUCTION OF GROWTH-PROMOTING AND CALCIFYING PROPERTIES IN A RATION BY EXPOSURE TO ULTRA-VIOLET LIGHT , 1924 .
[80] E. V. Mccollum,et al. STUDIES ON EXPERIMENTAL RICKETS XXI. AN EXPERIMENTAL DEMONSTRATION OF THE EXISTENCE OF A VITAMIN WHICH PROMOTES CALCIUM DEPOSITION , 1922 .
[81] K. Huldschinsky. Heilung von Rachitis durch künstliche Höhensonne , 1919 .
[82] C. Funk. The preparation from yeast and certain foodstuffs of the substance the deficiency of which in diet occasions polyneuritis in birds , 1912, The Journal of physiology.
[83] F. G. Hopkins. Feeding experiments illustrating the importance of accessory factors in normal dietaries , 1912, The Journal of physiology.
[84] Justus. Justus Liebig's Annalen der Chemie und Pharmacie , 1874 .